BRAIN Biotech AG Ratios and Metrics

Market cap in millions EUR. Fiscal year is October - September.

Millions EUR. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan '26 Jan 29, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Market Capitalization	51	48	46	93	96	221
Market Cap Growth	-29.05%	2.83%	-50.00%	-3.85%	-56.34%	56.48%
Enterprise Value	65	37	35	89	83	213
Last Close Price	2.24	2.26	2.00	4.22	4.47	9.92
PS Ratio	1.01	0.95	0.84	1.65	1.92	5.63
PB Ratio	27.55	25.89	3.34	4.03	2.81	5.28
P/TBV Ratio	-	-	-	14.13	7.48	8.74
EV/Sales Ratio	1.30	0.74	0.62	1.58	1.65	5.44
Debt / Equity Ratio	11.27	11.27	1.89	0.45	0.31	0.27
Asset Turnover	0.65	0.65	0.70	0.76	0.65	0.52
Inventory Turnover	2.41	2.41	2.60	2.66	2.72	2.49
Quick Ratio	0.86	0.86	1.41	0.87	0.93	2.78
Current Ratio	1.42	1.42	1.83	1.46	1.42	3.45
Return on Equity (ROE)	-150.49%	-150.49%	-60.16%	-28.34%	-16.67%	-13.77%
Return on Assets (ROA)	-6.25%	-6.25%	-7.06%	-4.67%	-5.12%	-6.16%
Return on Capital Employed (ROCE)	-15.90%	-15.90%	-14.10%	-10.40%	-11.30%	-11.10%
Earnings Yield	-23.17%	-24.65%	-24.02%	-8.94%	-6.84%	-2.25%
FCF Yield	-21.24%	-22.60%	-11.09%	-7.38%	-7.56%	-2.34%
Buyback Yield / Dilution	-	-	-	-	-9.55%	-6.89%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.